EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells

TRAIL is a death receptor ligand that induces cell death preferentially in tumor cells. Recombinant soluble TRAIL, however, performs poorly as an anti-cancer therapeutic because oligomerization is required for potent biological activity. We previously generated a diabody format of tumor-targeted TRA...

Descripción completa

Detalles Bibliográficos
Autores principales: Möller, Yvonne, Siegemund, Martin, Beyes, Sven, Herr, Ricarda, Lecis, Daniele, Delia, Domenico, Kontermann, Roland, Brummer, Tilman, Pfizenmaier, Klaus, Olayioye, Monilola A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157814/
https://www.ncbi.nlm.nih.gov/pubmed/25198428
http://dx.doi.org/10.1371/journal.pone.0107165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157814/
https://www.ncbi.nlm.nih.gov/pubmed/25198428
http://dx.doi.org/10.1371/journal.pone.0107165

Ejemplares similares